Pancreatitis clinical trials

Explore recruiting pancreatitis clinical trials.

Recruiting pancreatitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pancreatitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Simvastatin in the Prevention of Recurrent Pancreatitis, a Triple Blind, Randomized Controlled Trial.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Tacrolimus as prophylaxis of post-ERCP pancreatitis: a DPSG (Dutch Pancreatitis Study Group) multicenter, double-blind, randomized, placebo-controlled study.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Pancreatitis and early omega-3-fatty acid infusion for reduction of organ failure and mortality: a multicenter randomized controlled trial (PLANCTON).

Netherlands, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Normal saline versus lactated Ringer’s solution for acute pancreatitis resuscitation, an open-label multicenter randomized controlled trial: the WATERLAND trial

Spain, France

Therapeutic use (Phase IV) EU CTIS Study details

Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled trial.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Ursodeoxycolic acid for the prevention of relapsing complications after gallstone acute pancreatitis, a double-blind multicenter randomized-controlled trial.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Pancreatitis trials by city

Pancreatitis in Toronto Pancreatitis in Vancouver Pancreatitis in Montreal Pancreatitis in Calgary Pancreatitis in Edmonton Pancreatitis in Ottawa Pancreatitis in Winnipeg Pancreatitis in Quebec City Pancreatitis in Hamilton Pancreatitis in Kitchener Pancreatitis in London Pancreatitis in Halifax Pancreatitis in New York Pancreatitis in Los Angeles Pancreatitis in Chicago Pancreatitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease